48S-33309-50801
4 vaccinations
5 coded responses
42 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 337 / FL
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-07
Dose 1 — Moderna
-
2021-04-10
Registered in v-safe
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
-
2021-04-21
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site reaction, Injection site warmth — Feeling: GoodFree text: On the morning of Friday, April 16, a slightly raised red spot appeared on my left arm in the vicinity of the injection site, slightly warm to touch. The spot disappeared by evening.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-30
-
2021-05-05
Dose 2 — Moderna
- 2021-05-05
- 2021-05-05
-
2021-05-06
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Low appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-19
- 2021-05-26
- 2021-06-16
- 2021-08-04
-
2021-11-05
Survey response — 6 months, dose 2MedDRA: Sinus disorder, Sneezing — Feeling: GoodFree text: Sneezing, sinus irritation.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Dose 3 — Moderna
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-29
-
2021-11-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-06
- 2021-12-11
- 2021-12-18
- 2022-01-01
- 2022-01-09
-
2022-02-28
Survey response — 3 months, dose 3MedDRA: Cough, Fatigue, Headache, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test negative, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: From January 28 through February 3, I experienced cold-like symptoms including sinus, runny nose, cough, headache, and fatigue. Four rapid COVID tests taken during this period all returned negative results.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-29
Survey response — 12 months, dose 3MedDRA: Cough, Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore throat, cough, nasal congestion, runny nose, lasting 4-5 days in early November.MedDRA releases: 2024-11 · check-in free text available
-
2023-01-07
Dose 4 — ModernaCo-administered: Flu
-
2023-01-08
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2023-01-09
- 2023-01-11
- 2023-01-12
- 2023-01-14
- 2023-01-21
- 2023-01-28
- 2023-02-05
- 2023-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Moderna | |
| 2 | 2021-05-05 | Moderna | |
| 3 | 2021-11-27 | Moderna | No |
| 4 | 2023-01-07 | Moderna | Flu |
Free text
Release 7 — day 14, dose 1
Symptoms: On the morning of Friday, April 16, a slightly raised red spot appeared on my left arm in the vicinity of the injection site, slightly warm to touch. The spot disappeared by evening.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Low appetite
Release 10 — 6 months, dose 2
Symptoms: Sneezing, sinus irritation.
Release 11 — 3 months, dose 3
Symptoms: From January 28 through February 3, I experienced cold-like symptoms including sinus, runny nose, cough, headache, and fatigue. Four rapid COVID tests taken during this period all returned negative results.
Release 12 — 12 months, dose 3
Symptoms: Sore throat, cough, nasal congestion, runny nose, lasting 4-5 days in early November.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site reaction | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release